Pregnancy News and Research

Latest Pregnancy News and Research

World Breastfeeding Week highlights benefits to infant, child nutrition, health

Kicking off World Breastfeeding Week Sunday, the WHO together with UNICEF emphasized the importance of the agencies' 10 steps to successful breastfeeding to improve health of infants and children around the world, VOA News reports (Schlein, 8/1).

3 Aug 2010

Aetna offers two RHP plans for companies in need of health care cover

Companies operating across the Middle East now have a new choice in health benefits plans from Aetna Global Benefits (AGB), the international business segment of Aetna, that provides additional flexibility in cover and affordability. The organisation has expanded its Regional Healthcare Plan (RHP) for companies in need of health care cover for their expatriate employees living across the region.

2 Aug 2010

Stop & Shop Supermarket announces voluntary recall of Nature's Promise Alfalfa, Zesty Sprouts

The Stop & Shop Supermarket Company has announced a voluntary recall of Nature's Promise Alfalfa and Zesty Sprouts because they have the potential to be contaminated with listeria monocytogenes.

31 Jul 2010

Be a Hero For Babies Day raises more than $2.65M to support March of Dimes programs

With local telethons, carwashes, golf outings, pancake breakfasts, pie-throwing contests and a television partnership, Farmers Insurance Group and its agents nationwide led their communities to raise more than $2.65 million in a one-day fundraiser, Be a Hero for Babies Day, on July 22 to support March of Dimes programs to give every baby a healthy start in life.

31 Jul 2010

VBDS secondary to nevirapine use in HIV-positive, pregnant female: Report

Vanishing bile duct syndrome refers to a group of disorders characterized by destruction and disappearance of intrahepatic (inside the liver) bile ducts. Multiple causes have been identified including infections, malignancies, autoimmune conditions and adverse effects of medications. The usual course of this condition is variable and many patients with VBDS respond to treatment of the underlying condition and/ or removal of the offending agent. However, others progress to cirrhosis and end stage liver disease requiring liver transplantation.

31 Jul 2010

Oral contraceptives, HRT may protect women against formation, rupture of brain aneurysms: Study

Results from a new study suggest that oral contraceptives and hormone replacement therapy may yield additional benefit of protecting against the formation and rupture of brain aneurysms in women. The findings from this first-of-its-kind study by a neurointerventional expert from Rush University Medical Center were presented at the Society of Neurointerventional Surgery 7th annual meeting.

31 Jul 2010

Study shows estrogen stabilization may protect women from brain aneurysms risk

Results from a retrospective, case-control study presented today at the Society of NeuroInterventional Surgery (SNIS) 7th Annual Meeting could have significant implications for women at risk of brain aneurysms as data shows that oral contraceptives (OC) and hormone replacement therapy (HRT) may yield the additional benefit of protecting against the formation and/or rupture of brain aneurysms – balloon-like sacks that form in a weakened artery wall and, upon bursting, can cause severe disability or death.

31 Jul 2010

Ten steps to successful breastfeeding from WHO and UNICEF

During World Breastfeeding Week, celebrated from 1 to 7 August in more than 170 countries, WHO reiterates its call on health facilities and health workers to implement ten steps to help mothers breastfeed successfully and improve their babies' health and chances of survival.

30 Jul 2010

$Pivotal PINNACLE trial results of VELCADE in patients with relapsed/refractory MCL released$

Pivotal PINNACLE trial results of VELCADE in patients with relapsed/refractory MCL released

Millennium: The Takeda Oncology Company today reported new correlative science data from the pivotal PINNACLE trial of VELCADE (bortezomib) in patients with relapsed/refractory mantle cell lymphoma. The data, derived from an analysis of archived tumor samples, tested pre-specified biomarkers for their association with time to progression and response to treatment with VELCADE in patients with relapsed MCL.

30 Jul 2010

New health reform law to benefit 30 million women: Commonwealth Fund report

Thirty million women will benefit from the new health reform law over the next decade, either through new or strengthened insurance coverage, according to a new report from The Commonwealth Fund. In the first analysis of its kind, the authors report that the law will stabilize and reverse the growing exposure to health costs that women now experience by subsidizing health insurance for up to 15 million currently uninsured women, and strengthening existing coverage for 14.5 million women who are considered underinsured-those who have health coverage that does not adequately protect them from high medical expenses.

30 Jul 2010

VitaPath Genetics launches VitaTrack Folate Tracker

VitaPath Genetics, the Spina Bifida Association and the National Council on Folic Acid today announced the launch of the free iPhone application—the VitaTrack Folate Tracker— which allows women to track their daily intake of folate and folic acid. Maintaining an adequate level of folic acid prior to and during pregnancy can reduce the risk of serious birth defects like Spina Bifida by up to 70%. Studies show that folic acid may also help prevent congenital heart disease, pre-term labor, and cleft lip and palate.

30 Jul 2010

Western dietary pattern increases risk of ADHD

A new study from Perth's Telethon Institute for Child Health Research shows an association between ADHD and a 'Western-style' diet in adolescents.The research findings have just been published online in the international Journal of Attention Disorders."We found a diet high in the Western pattern of foods was associated with more than double the risk of having an ADHD diagnosis compared with a diet low in the Western pattern, after adjusting for numerous other social and family influences," Dr Oddy said.

30 Jul 2010

Transforaminal injection of steroids is a viable alternative for lumbar radicular pain surgery

A recent study from Australian researchers determined that transforaminal injection of steroids was a viable alternative to surgery for lumbar radicular pain due to disc herniation. Full details of the study appear in the August issue of Pain Medicine, a journal published by Wiley-Blackwell on behalf of the American Academy of Pain Medicine, the Faculty of Pain Medicine of the Australian and New Zealand College of Anaesthetists, and the International Spine Intervention Society.

30 Jul 2010

Quidel second-quarter total revenues increase 1.6% to $25.0 million

Quidel Corporation, a leading provider of rapid diagnostic testing solutions, announced today financial results for the second quarter ended June 30, 2010.

30 Jul 2010

Senate Commission presents 2010 list of MAK and BAT values containing new data on 61 substances

The Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) Senate Commission for the Investigation of Health Hazards of Chemical Compounds in the Work Area has presented the 2010 list of MAK and BAT values containing new data on 61 substances. These values for the classification of health hazards constituted by work area substances have been adjusted this year.

29 Jul 2010

Safeguard Scientifics second-quarter aggregate revenue of partner companies increase 47% to $91.6 million

Safeguard Scientifics, Inc., a holding company that builds value in growth-stage life sciences and technology companies, today announced that aggregate revenue of its partner companies for the three months ended June 30, 2010 was $91.6 million, up 47% from $62.3 million for the same partner companies in the same period of 2009. For the six months ended June 30, 2010, the aggregate partner company revenue was $176.9 million, up 45% from $121.8 million for the same partner companies for the same period of 2009.

29 Jul 2010

Rotigotine provides clinically relevant improvements in RLS symptoms: Study

UCB today announced the results of a 6-month, randomized, double-blind, placebo-controlled clinical study, published in the journal Movement Disorders, showing that Neupro® (rotigotine transdermal system, 2 and 3 mg/24 hours) provided sustained, clinically relevant improvements in symptoms of Restless Legs Syndrome (RLS). The study also showed high rates of complete remission seen with rotigotine 2 mg or 3 mg/24 hours.

29 Jul 2010

Merck signs non-exclusive license agreement with LabCorp for commercialization of genetic test

Merck announced a non-exclusive license agreement with Laboratory Corporation of America Holdings for the commercialization of a genetic test that may help predict the response of patients with Hepatitis C virus infection to peginterferon alpha-based therapy.

28 Jul 2010

Late preterm births risk infant respiratory illness: Study

Babies born between 34 weeks and 37 weeks gestation are much more likely to have respiratory illness compared to infants born at full term, and their risk of respiratory illness decreases with each additional week of gestation until 38 weeks, researchers report.

28 Jul 2010

DIATHERIX Laboratories opens rapid response diagnostic panels for STD, HSV

DIATHERIX Laboratories ,adds a Sexually Transmitted Disease (STD) panel and Herpes Simplex Virus (HSV) panel to its line up of highly sensitive, rapid response diagnostic panels. The HSV panel identifies herpes simplex viruses 1 and 2 and the STD panel identifies 10 sexually transmitted diseases simultaneously, many of which cannot be accurately identified by current testing methods. These STD organisms, if not appropriately treated, can cause diseases such as syphilis, gonorrhoeae, chlamydia, bacterial vaginosis, etc. and may lead to blindness, infertility or complications during pregnancy.

28 Jul 2010

Pregnancy News and Research

Latest Pregnancy News and Research

World Breastfeeding Week highlights benefits to infant, child nutrition, health

Aetna offers two RHP plans for companies in need of health care cover

Stop & Shop Supermarket announces voluntary recall of Nature's Promise Alfalfa, Zesty Sprouts

Be a Hero For Babies Day raises more than $2.65M to support March of Dimes programs

VBDS secondary to nevirapine use in HIV-positive, pregnant female: Report

Oral contraceptives, HRT may protect women against formation, rupture of brain aneurysms: Study

Study shows estrogen stabilization may protect women from brain aneurysms risk

Ten steps to successful breastfeeding from WHO and UNICEF

Pivotal PINNACLE trial results of VELCADE in patients with relapsed/refractory MCL released

New health reform law to benefit 30 million women: Commonwealth Fund report

VitaPath Genetics launches VitaTrack Folate Tracker

Western dietary pattern increases risk of ADHD

Transforaminal injection of steroids is a viable alternative for lumbar radicular pain surgery

Quidel second-quarter total revenues increase 1.6% to $25.0 million

Senate Commission presents 2010 list of MAK and BAT values containing new data on 61 substances

Safeguard Scientifics second-quarter aggregate revenue of partner companies increase 47% to $91.6 million

Rotigotine provides clinically relevant improvements in RLS symptoms: Study

Merck signs non-exclusive license agreement with LabCorp for commercialization of genetic test

Late preterm births risk infant respiratory illness: Study

DIATHERIX Laboratories opens rapid response diagnostic panels for STD, HSV

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Pregnancy News and Research

Latest Pregnancy News and Research

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Newsletters you may be interested in